发明公开
- 专利标题： DRUG FOR TREATING TUMOR
-
申请号： EP21833511.5申请日： 2021-06-30
-
公开(公告)号： EP4174087A1公开(公告)日： 2023-05-03
- 发明人: SU, Nan , ZHANG, Xiquan , CHEN, Jie , WANG, Xunqiang , LI, Kun , YU, Ding , WANG, Rongliang
- 申请人： CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
- 申请人地址： CN Lianyungang, Jiangsu 222062 No. 369 Yuzhou South Rd.,
- 代理机构： v. Bezold & Partner Patentanwälte - PartG mbB
- 优先权： CN202010620778 20200630
- 国际公布： WO2022002153 20220106
- 主分类号： C07K16/28
- IPC分类号： C07K16/28 ; C12N15/13 ; A61K39/395 ; A61P37/02
摘要：
The present invention belongs to the field of biomedicines, relates to a drug for treating tumors, and provides use of an anti-PD-L1 antibody or a pharmaceutical composition thereof in preparation of a drug for treating endometrial cancer. Also provided is use of the anti-PD-L1 antibody or the pharmaceutical composition thereof in preparation of a drug for treating a MSI-H and/or dMMR tumor. In addition, also provided is use of a pharmaceutical combination of the anti-PD-L1 antibody and Anlotinib or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition thereof in preparation of a drug for treating endometrial cancer.
信息查询
